Loading stock data…
PACB
$1.60+0.01 (+0.63%)
Market ClosedLast close May 1
Pacific Biosciences of California, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Pacific Biosciences of California, Inc. in the Healthcare sector is trading at $1.60. The stock is currently 41% below its 52-week high of $2.73, remaining 4.8% below its 200-day moving average. Technical signals show neutral RSI of 60 and bearish MACD signal, explaining why PACB maintains its current current market pressure. The Whystock Score of 15/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 60) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.60
Potential Upside
5%
Whystock Fair Value$1.68
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technol...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$516.42M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.33
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-9840.33%
Volume
Today's trading volume
4.99M
Recent News
OrthoPediatrics (KIDS) Reports Q1 Loss, Beats Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -10.53% and +2.15%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California (PACB) Dips More Than Broader Market: What You Should Know
In the closing of the recent trading day, Pacific Biosciences of California (PACB) stood at $1.47, denoting a -6.96% move from the preceding trading day.
Pacific Biosciences of California (PACB) Stock Declines While Market Improves: Some Information for Investors
In the latest trading session, Pacific Biosciences of California (PACB) closed at $1.71, marking a -1.16% move from the previous day.
GEHC & DeepHealth Advance AI Breast Cancer Screening Globally
GE HealthCare expands DeepHealth tie-up to roll out AI-powered mammography tools, improving early breast cancer detection and advancing women's health.
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session as the reopening of the Strait of Hormuz signaled a cooling of global logistics and energy costs.